| |
| |
|
| Insider
Information: |
Tarriff Scott |
| Relationship: |
Director |
| City: |
Mahwah |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
764,807 |
|
|
Indirect Shares
|
992,623 |
|
|
| Direct
Value |
$1,802,172 |
|
|
|
Indirect Value
|
$3,781,894 |
|
|
| Total
Shares |
1,757,430 |
|
|
| Total
Value |
$5,584,065 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -287.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director |
2011-04-12 |
0 |
2009-09-17 |
0 |
Premium* |
|
|
Eagle Pharmaceuticals, Inc. |
EGRX |
|
2024-02-28 |
460,621 |
2024-02-28 |
992,623 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director |
2015-09-25 |
4,186 |
2015-09-25 |
0 |
Premium* |
|
|
Theriva Biologics Ord Shs |
TOVX |
Director |
2016-11-18 |
300,000 |
2016-11-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDA |
Clinical Data Inc |
Director |
– • – |
2009-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • – |
2010-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,600 |
16,600 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
196,485 |
1,668,859 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2015-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,186 |
4,186 |
0 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
Director |
– • – |
2016-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
300,000 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
61,300 |
1,579,690 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2020-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
58,300 |
1,558,502 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
34,800 |
1,579,706 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
70,900 |
1,639,934 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
|
– – • |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
12,950 |
465,894 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • • |
2015-03-20 |
4 |
AS |
$42.00 |
$5,040,000 |
D/D |
(120,000) |
1,549,622 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • • |
2015-07-01 |
4 |
AS |
$77.58 |
$1,248,855 |
D/D |
(15,710) |
1,533,912 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • – |
2015-08-03 |
4 |
AS |
$95.39 |
$1,250,408 |
D/D |
(13,000) |
1,520,912 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • – |
2015-09-01 |
4 |
AS |
$75.12 |
$1,249,998 |
D/D |
(16,245) |
1,504,667 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • – |
2015-10-01 |
4 |
AS |
$68.50 |
$1,249,965 |
D/D |
(17,878) |
1,486,789 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • – |
2015-11-02 |
4 |
AS |
$64.07 |
$1,249,955 |
D/D |
(19,339) |
1,467,450 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • – |
2015-12-01 |
4 |
AS |
$86.92 |
$1,249,419 |
D/D |
(14,050) |
1,453,400 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • – |
2016-01-04 |
4 |
AS |
$85.65 |
$1,249,921 |
D/D |
(14,549) |
1,438,851 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • – |
2016-02-01 |
4 |
AS |
$66.03 |
$1,249,974 |
D/D |
(18,360) |
1,420,491 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • – |
2016-03-01 |
4 |
AS |
$62.70 |
$1,250,028 |
D/D |
(19,780) |
1,400,711 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
President and CEO |
• • – |
2016-04-01 |
4 |
AS |
$40.63 |
$1,249,982 |
D/D |
(30,765) |
1,369,946 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-01-02 |
4 |
AS |
$39.30 |
$595,705 |
D/D |
(15,000) |
1,534,959 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-01-03 |
4 |
AS |
$39.04 |
$651,058 |
D/D |
(16,569) |
1,518,390 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-02-01 |
4 |
AS |
$41.52 |
$1,249,831 |
D/D |
(30,085) |
1,549,605 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
CEO |
• • • |
2019-03-01 |
4 |
AS |
$50.51 |
$1,250,015 |
D/D |
(24,428) |
1,525,177 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
